Need Help? Call 1­-866-­796-­7386
« back to stock screener

  CRL stock: Charles River Laboratories Int

Current Rating
Buy

Previous Rating

Hold/Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$270.95
Market Cap
8.96B
Sector
Health Care
Div. Growth
-
P/E
19.3
P/B
2.87
P/S
2.23
Dividend %
-
P/CF
-
P/FCF
32.3
Op. Cash Flow
625K
FCF
5.6
Op. Margin
18.50%
Net Margin
11.60%
ROE
16.20%
ROI
9.50%
ROA
6.40%
EPS Growth
8.30%
Current Ratio
1.3
Debt/Equity
91.00%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Cidara Therapeutics Inc (CDTX) $0.92 - - 78M Strong Buy
Interpace Biosciences Inc (IDXG) $1.50 - - 4.1M Strong Buy
Jazz Pharmaceuticals PLC (JAZZ) $120.42 - - 8.13B Strong Buy
Bimi International Medical Inc (BIMI) $1.68 - - 6.4M Strong Buy
Journey Medical Corp (DERM) $3.68 - - 43.3M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More